Skip to main content

Advertisement

SpringerLink
Log in

Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient

  • Letter to the Editor
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Geukes Foppen MH, Brandsma D, Blank CU et al (2016) Targeted treatment and immunotherapy in leptomeningeal metastases from melanoma. Ann Oncol 27:1138–1142

    Article  CAS  PubMed  Google Scholar 

  2. Simeone E, De Maio E, Sandomenico F et al (2012) Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib (a V600EBRAF inhibitor): a case report. J Med Case Rep 6:131

    Article  PubMed  PubMed Central  Google Scholar 

  3. Sakji-Dupre L, Le Rhun E, Templier C et al (2015) Cerebrospinal fluid concentrations of vemurafenib in patients treated for brain metastatic BRAF-V600 mutated melanoma. Melanoma Res 25:302–305

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This report was not supported by any funding.

Author information

Authors and Affiliations

  1. Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Isabella C. Glitza

  2. Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Sherise D. Ferguson

  3. Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Nandita Guha-Thakurta

Authors
  1. Isabella C. Glitza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sherise D. Ferguson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nandita Guha-Thakurta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Isabella C. Glitza.

Ethics declarations

Conflict of interest

All three authors have no conflict of interest.

Informed consent

This article does not contain any studies with human participants or animals performed by any of the authors, and the reported patient was treated with standard of care therapy after informed consent was obtained.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Glitza, I.C., Ferguson, S.D. & Guha-Thakurta, N. Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient. J Neurooncol 133, 663–665 (2017). https://doi.org/10.1007/s11060-017-2472-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-017-2472-2

Keywords

Search

Navigation